Your browser doesn't support javascript.
loading
Glutathione synthesis in the mouse liver supports lipid abundance through NRF2 repression.
Asantewaa, Gloria; Tuttle, Emily T; Ward, Nathan P; Kang, Yun Pyo; Kim, Yumi; Kavanagh, Madeline E; Girnius, Nomeda; Chen, Ying; Rodriguez, Katherine; Hecht, Fabio; Zocchi, Marco; Smorodintsev-Schiller, Leonid; Scales, TashJaé Q; Taylor, Kira; Alimohammadi, Fatemeh; Duncan, Renae P; Sechrist, Zachary R; Agostini-Vulaj, Diana; Schafer, Xenia L; Chang, Hayley; Smith, Zachary R; O'Connor, Thomas N; Whelan, Sarah; Selfors, Laura M; Crowdis, Jett; Gray, G Kenneth; Bronson, Roderick T; Brenner, Dirk; Rufini, Alessandro; Dirksen, Robert T; Hezel, Aram F; Huber, Aaron R; Munger, Joshua; Cravatt, Benjamin F; Vasiliou, Vasilis; Cole, Calvin L; DeNicola, Gina M; Harris, Isaac S.
Afiliação
  • Asantewaa G; Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, USA.
  • Tuttle ET; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
  • Ward NP; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Kang YP; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
  • Kim Y; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Kavanagh ME; Department of Metabolism and Physiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Girnius N; Department of Metabolism and Physiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Chen Y; Department of Metabolism and Physiology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Rodriguez K; Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • Hecht F; Leiden Institute of Chemistry, Leiden University, Leiden, the Netherlands.
  • Zocchi M; Department of Cell Biology, Harvard Medical School, Boston, MA, USA.
  • Smorodintsev-Schiller L; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA.
  • Scales TQ; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
  • Taylor K; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Alimohammadi F; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
  • Duncan RP; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Sechrist ZR; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
  • Agostini-Vulaj D; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Schafer XL; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
  • Chang H; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Smith ZR; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
  • O'Connor TN; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Whelan S; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
  • Selfors LM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Crowdis J; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Gray GK; Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY, USA.
  • Bronson RT; Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.
  • Brenner D; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Rufini A; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Dirksen RT; Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.
  • Hezel AF; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Huber AR; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
  • Munger J; Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY, USA.
  • Cravatt BF; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
  • Vasiliou V; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Cole CL; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
  • DeNicola GM; Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.
  • Harris IS; Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY, USA.
Nat Commun ; 15(1): 6152, 2024 Jul 21.
Article em En | MEDLINE | ID: mdl-39034312
ABSTRACT
Cells rely on antioxidants to survive. The most abundant antioxidant is glutathione (GSH). The synthesis of GSH is non-redundantly controlled by the glutamate-cysteine ligase catalytic subunit (GCLC). GSH imbalance is implicated in many diseases, but the requirement for GSH in adult tissues is unclear. To interrogate this, we have developed a series of in vivo models to induce Gclc deletion in adult animals. We find that GSH is essential to lipid abundance in vivo. GSH levels are highest in liver tissue, which is also a hub for lipid production. While the loss of GSH does not cause liver failure, it decreases lipogenic enzyme expression, circulating triglyceride levels, and fat stores. Mechanistically, we find that GSH promotes lipid abundance by repressing NRF2, a transcription factor induced by oxidative stress. These studies identify GSH as a fulcrum in the liver's balance of redox buffering and triglyceride production.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triglicerídeos / Fator 2 Relacionado a NF-E2 / Glutamato-Cisteína Ligase / Glutationa / Fígado Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triglicerídeos / Fator 2 Relacionado a NF-E2 / Glutamato-Cisteína Ligase / Glutationa / Fígado Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article